Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss
about
Photoreceptor inner segment ellipsoid band integrity on spectral domain optical coherence tomographyAdaptive optics retinal imaging--clinical opportunities and challengesThe reliability of parafoveal cone density measurements.The impact of different algorithms for ideal body weight on screening for hydroxychloroquine retinopathy in women.Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the "flying saucer" sign)Dark-adaptation functions in molecularly confirmed achromatopsia and the implications for assessment in retinal therapy trials.Retinal toxicity associated with chronic exposure to hydroxychloroquine and its ocular screening. Review.Retinal damage in chloroquine maculopathy, revealed by high resolution imaging: a case report utilizing adaptive optics scanning laser ophthalmoscopy.Photoreceptor structure and function in patients with congenital achromatopsia.Spectral-Domain Optical Coherence Tomography of Preclinical Chloroquine Maculopathy in Egyptian Rheumatoid Arthritis Patients.The use of time-lapse optical coherence tomography to image the effects of microapplied toxins on the retina.Spectral domain optical coherence tomography for early detection of retinal alterations in patients using hydroxychloroquineMicroperimetric sensitivity in patients on hydroxychloroquine (Plaquenil) therapy.Outer retinal structure in best vitelliform macular dystrophyHydroxychloroquine retinopathy.Screening for chloroquine maculopathy in populations with uncertain reliability in outcomes of automatic visual field testingPhotoreceptor-Based Biomarkers in AOSLO Retinal Imaging.Imaging in vitreoretinal diagnostics.Perifoveal interdigitation zone loss in hydroxychloroquine toxicity leads to subclinical bull's eye lesion appearance on near-infrared reflectance imaging.
P2860
Q27021797-375F1284-7D7A-45CC-885A-6F3413C5E0C9Q33649997-5377D978-FDC8-4205-941B-57D7AED057B9Q33956362-B50ABE25-C1F0-44B6-BEEE-852A039C8346Q33976159-9D46EB50-996A-4E79-8B55-3C258E6E6D7AQ34245232-7FC4FE80-DDE2-464C-B27E-7B6F99FDAC7CQ34323173-6FB60711-2BB2-4D9B-81AD-1BEAA96BE833Q34520106-13722AC0-C1BE-4ED7-AD81-1740773E79A8Q35087997-34D6FDDD-0AEC-4EE1-8EF0-89D1BD201EA9Q35247580-80CA5FAD-CBD4-4575-A3B1-E01D098AF290Q35957874-01A27037-7BA8-471A-B8AE-E9FF0E96242CQ35981274-3B05C33B-D83B-4F06-AC03-E74784D2A351Q37023500-EA45749C-4669-4D94-994A-107EC31259B1Q37168797-5B9AC651-E4B9-4702-BE16-3D7A19B1EBDEQ37670152-43DB78E7-84D8-4C5E-9964-E438EEE702BDQ39172826-1F1EF575-E313-4DF6-9F93-F85F3CCBD36CQ39396583-C84F86CB-2D9E-45B4-848F-85B3B958FD69Q41615277-79898A98-E465-4763-9CDA-1CB3F6D85AF6Q43086984-43359F55-6299-4B0F-8296-B35D877FEC1FQ50076154-E01840E0-2D9C-49A5-808F-C2F3056894DA
P2860
Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Spectral-domain optical cohere ...... before symptomatic vision loss
@ast
Spectral-domain optical cohere ...... before symptomatic vision loss
@en
type
label
Spectral-domain optical cohere ...... before symptomatic vision loss
@ast
Spectral-domain optical cohere ...... before symptomatic vision loss
@en
prefLabel
Spectral-domain optical cohere ...... before symptomatic vision loss
@ast
Spectral-domain optical cohere ...... before symptomatic vision loss
@en
P2093
P2860
P1476
Spectral-domain optical cohere ...... before symptomatic vision loss
@en
P2093
Dennis P Han
Jonathan Schell
Joseph Carroll
Jungtae Rha
Kimberly E Stepien
Pooja Godara
P2860
P577
2009-12-01T00:00:00Z